Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides

Curr Hematol Malig Rep. 2016 Jun;11(3):224-33. doi: 10.1007/s11899-016-0322-5.

Abstract

Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.

Keywords: Cutaneous T-cell lymphoma; Multidisciplinary approach; Non-mycosis fungoides; Primary cutaneous B-cell lymphoma; Skin-directed treatment; Systemic treatment.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Lymphoma, B-Cell / diagnosis*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / radiotherapy
  • Lymphoma, T-Cell / diagnosis*
  • Lymphoma, T-Cell / drug therapy
  • Lymphoma, T-Cell / radiotherapy
  • Mycosis Fungoides / diagnosis
  • Mycosis Fungoides / drug therapy
  • Practice Guidelines as Topic
  • Recurrence
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / radiotherapy
  • Translocation, Genetic